Quantitative real-time PCR assay with immunohistochemical evaluation of HER2/neu oncogene in breast cancer patients and its correlation with clinicopathological findings
Human epidermal growth factor receptor HER2/neu status is an important prognostic factor for breast cancer as it is crucial in stimulating growth and cellular motility. Overexpression of HER2/neu is observed in 10%−35% of the human breast cancer and is associated with prognosis and response to treat...
Saved in:
Main Authors: | Nadia Gheni (Author), David Westenberg (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of HER2/neu Expression in High-Grade Endometrial Carcinoma and Its Clinicopathological Correlation
by: Soheila Sarmadi, et al.
Published: (2019) -
Evaluation Of Immunohistochemical Expression Of Her2/Neu In Prostate Adenocarcinoma
by: Santosh Kumar Sidhwani, et al.
Published: (2024) -
The expression of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2-neu, p53 and Ki-67 in epithelial ovarian tumors and its correlation with clinicopathologic variables
by: Mary T Sylvia, et al.
Published: (2012) -
Cytological grading of breast carcinomas correlating with ultrasonographic findings, histopathologic grade and Her2neu oncogene status in women of age group thirty to sixty five years
by: Ena Dowerah, et al.
Published: (2013) -
Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer
by: Tyler Keay, et al.
Published: (2013)